NCT06887933 2025-03-21
A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer
GlaxoSmithKline
Phase 4 Not yet recruiting
Clinical Trials
4 trialsNCT06258018 2024-08-30
ONC-2022-001
Istituto Clinico Humanitas
Phase 1/2 Not yet recruiting
NCT06237205 2024-02-01
Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency
Korea University Anam Hospital
Phase 2 Not yet recruiting
NCT05232006 2022-03-08
PALB2-PARPi-01
Assistance Publique - Hôpitaux de Paris
Phase 2 Not yet recruiting